CART123 T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CART123 T Cells, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial [EARLY_Phase 1]